Australia, May 28 -- CELLTRION Inc., owns the trademark (2630638) for 'OLYMAVUS' till Jan. 19, 2036.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for human use; antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the treatment of inflammatory diseases.]
Type of Mark: Word
Date of Acceptance: March 20
Registration Advertised: May 27
For further details contact JIDAM IP LAW FIRM.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2630638.
Disclaimer: Curated by HT Syndication.
